{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:21:19Z","timestamp":1764332479314},"reference-count":36,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2017,6,3]]},"DOI":"10.1080\/03007995.2017.1308918","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T13:16:13Z","timestamp":1490015773000},"page":"1127-1132","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records"],"prefix":"10.1080","volume":"33","author":[{"given":"Frank A.","family":"Corvino","sequence":"first","affiliation":[{"name":"Genesis Research, Hoboken, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Oliveri","sequence":"additional","affiliation":[{"name":"Genesis Research, Hoboken, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Health Economics & Outcomes Research, EMD Serono, Inc., Rockland, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61620-7"},{"key":"CIT0002","unstructured":"Relapsing\u2013remitting MS (RRMS). National Multiple Sclerosis Society, 2016. Available at: http:\/\/www.nationalmssociety.org\/What-is-MS\/Types-of-MS\/Relapsing-remitting-MS [Last accessed 16 March 2016]"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61768-1"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114287"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03334-0"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12269"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514546788"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31818f3d6f"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1177\/1352458509107007"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-11-122"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.991314"},{"key":"CIT0012","unstructured":"Electronic Health Records. Centers for Medicare & Medicaid Services (CMS), 2012. Available at: https:\/\/www.cms.gov\/Medicare\/E-Health\/EHealthRecords\/index.html?redirect=\/ehealthrecords [Last accessed 24 February 2017]"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514538334"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000176"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2007.09.001"},{"key":"CIT0016","first-page":"277","volume":"8","author":"Emir B","year":"2015","journal-title":"J Pain Res"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31829b1d48"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2013-001999"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078927"},{"key":"CIT0020","unstructured":"Humedica Life Sciences Detailed Clinical Data. Optum, 2016. Available at: http:\/\/www.humedica.com\/solutions\/life-sciences\/detailed-clinical-data\/ [Last accessed 16 March 2016]"},{"key":"CIT0021","volume-title":"The impact of timing of disease-modifying drug treatment initiation on multiple sclerosis relapse rates in newly diagnosed patients","author":"Phillips AL","year":"2015"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1014029"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2010.523670"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1177\/1352458516675039"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0627-1"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.235"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31819c95aa"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1197\/jamia.M1290"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S8230"},{"key":"CIT0032","first-page":"189","volume":"1","author":"Martin LR","year":"2005","journal-title":"Ther Clin Risk Manag"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.18553\/jmcp.2013.19.s1.S24","volume":"19","author":"Menzin J","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"CIT0034","unstructured":"Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. 2009. Available at: http:\/\/www.rand.org\/content\/dam\/rand\/pubs\/technical_reports\/2009\/RAND_TR765.pdf [Last accessed 16 March 2016]"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.31887\/DCNS.2011.13.2\/hmoeller","volume":"13","author":"Moller HJ.","year":"2011","journal-title":"Dialogues Clin Neurosci"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.2196\/ijmr.4549"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2017.1308918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T18:04:23Z","timestamp":1658858663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2017.1308918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6,3]]}},"alternative-id":["10.1080\/03007995.2017.1308918"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2017.1308918","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-12-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-04-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}